In IBS, Paeoniflorin and Changji’an Formula (CJAF) inhibited the altered activation of the NLRP3 inflammasome pathway and re-established the impaired intestinal barrier functions, increasing the tight junction proteins [163,164]. The gene discussed is NLRP3; the disease is irritable bowel syndrome.